BTMD

Biote Corp.

A maker of bioidentical hormone replacement therapy products, Biote Corp. trains and certifies doctors to implant tiny, grain-of-rice-sized hormone pellets under the skin, and supplies the kits, software, and marketing support their practices need. The company was founded in 2012 by OB/GYN Gary Donovitz, who turned to hormone therapy after seeing it transform a patient's life, and went public in 2022. Its name is a mashup of "bioidentical" and "testosterone."

CUSIP: 090683103HealthcareUS2 holders

Ownership Activity Financials Filings

BTMD

BTMD

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Regulation FD Disclosure

Results of Operations and Financial Condition

Other Events

Results of Operations and Financial Condition